Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MA 12 - Circumventing EGFR Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Wan Ling Tan, Nobuyuki Yamamoto
-
+
MA 12.01 - A Phase Ib Study of the Combination of Afatinib and Ruxolitinib in EGFR Mutant NSCLC Progressed on EGFR-TKI: An Updated Analysis
11:00 - 11:05 | Presenter: Ji Soo Park | Author(s): M.H. Hong, Byoung Chul Cho, Hye Ryun Kim
- Abstract
Loading... -
+
MA 12.02 - Phase I/II Study of S49076, a MET/AXL/FGFR Inhibitor, Combined with Gefitinib in NSCLC Patients Progressing on EGFR TKI
11:05 - 11:10 | Presenter: Gee-Chen Chang | Author(s): G. Curigliano, Wan-Teck Lim, S. Viteri, F. Ciardiello, T. Hida, Chia-Chi Lin, H. Murakami, Makoto Nishio, Luis Paz-Ares, F. Cantero, C. Gabarroca, E. Gandossi, N. Kamsu-Kom, S. Pennaforte, M.-. Secouard-Faure, Keunchil Park
- Abstract
Loading... -
+
MA 12.03 - Kinase Fusions as Recurrent Mechanisms of Acquired Resistance in EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
11:10 - 11:15 | Presenter: Sai-Hong Ignatius Ou | Author(s): S.J. Klempner, B. Creelan, W.S. Hsieh, D. Costin, P.J. Stephens, Jeffrey S. Ross, V.A. Miller, Siraj M Ali, A.B. Schrock
- Abstract
Loading... -
+
MA 12.04 - Discussant - MA 12.01, MA 12.02, MA 12.03
11:15 - 11:30 | Presenter: Miguel-Angel Molina-Vila
- Abstract
No abstract available for this presentation
-
+
MA 12.05 - Genomic Profiling of EGFR T790M Mutated Non-Small Cell Lung Cancer to Evaluate the Mechanisms of Resistance to Osimertinib
11:30 - 11:35 | Presenter: Sonam Puri | Author(s): J.K. Hicks, T.C. Knepper, M. Smith, T.A. Boyle, Jhanelle Elaine Gray
- Abstract
Loading... -
+
MA 12.06 - Using Population Dynamics Mathematical Modeling to Optimize an Intermittent Dosing Regimen for Osimertinib in EGFR-Mutant NSCLC
11:35 - 11:40 | Presenter: Xiuning Le | Author(s): S. Chakrabarti, F. Michor, D.B. Costa, Matthew Meyerson
- Abstract
Loading... -
+
MA 12.07 - Adjusted Indirect Comparison of Osimertinib to Chemotherapy in NSCLC Patients with EGFRm T790M Who Progressed after EGFR-TKI
11:40 - 11:45 | Presenter: Christopher Hoyle | Author(s): F. Andersohn, Tetsuya Mitsudomi, Tony SK Mok, James Chih-Hsin Yang, M. Green, H. Mann
- Abstract
Loading... -
+
MA 12.08 - Discussant - MA 12.05, MA 12.06, MA 12.07
11:45 - 12:00 | Presenter: Dae Ho Lee
- Abstract
No abstract available for this presentation
-
+
- Abstract
Loading... -
+
MA 12.10 - Clinical Utility of Plasma EGFR T790M Mutation Detection in Advanced Non-Small Cell Lung Cancer Patients According to RECIST Criteria
12:05 - 12:10 | Presenter: Lourdes Barrera | Author(s): J.R. Borbolla-Escoboza, E. Montes-Servin, E.O. Macedo-Perez, Feliciano Barron, C. Molina Romero, J.M. Hernandez Martinez, Oscar Arrieta
- Abstract
Loading... -
+
MA 12.11 - The Alteration of T790M Prevalence Between 19 Deletions and L858R in NSCLC After EGFR-TKIs Therapy, a Meta-Analysis
12:10 - 12:15 | Presenter: Hengrui Liang | Author(s): D. Chen, J. He, W. Liang
- Abstract
Loading... -
+
MA 12.12 - Discussant - MA 12.09, MA 12.10, MA 12.11
12:15 - 12:30 | Presenter: Kenneth Obyrne
- Abstract
No abstract available for this presentation
-
+
OA 09 - EGFR TKI Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:Thanyanan Reungwetwattana, Lecia V Sequist
-
+
OA 09.07 - Clonality of c-MET Copy Number Gain as a Determinant of Primary TKI Resistance in EGFR-Mutant NSCLC
12:05 - 12:15 | Presenter: Gillianne Lai | Author(s): R. Nahar, T. Lim, X. Kwang, P.J.R. Liew, J. Lim, Z.W. Aung, A. Takano, Wan-Teck Lim, D.P. Lau, Wan Ling Tan, M. Ang, C.K. Toh, B.S. Tan, A. Devanand, C.W. Too, A. Gogna, B.H. Ong, Tina Koh, R. Kanesvaran, Q.S. Ng, A. Jain, J. Yuan, T.K. Lim, A.S. Lim, A. Hillmer, W. Zhai, G. Iyer, E.H. Tan, W. Tam, Daniel SW Tan
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-017 - Clinical Outcomes of Patients with EGFR T790M + NSCLC on Osimertinib
09:30 - 09:30 | Presenter: Wan Ling Tan | Author(s): T.P. Hennedige, Q.S. Ng, S.H. Tan, N.T.A. Tran, B.J.G. Chua, C.K. Toh, E.H. Tan, Daniel SW Tan, M. Ang, R. Kanesvaran, A. Jain, T.K.H. Lim, A. Gogna, M. Koh, C.S.P. Yip, C.H. Thng, B. Chowbay, M.H. Tan, Wan-Teck Lim
- Abstract
Loading...